Nutrition Effects on Ocular Diseases in the Aging Eye
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
PURPOSE: We reviewed the data from the clinical trials of nutritional supplements for the treatment of age-related cataract and age-related macular degeneration (AMD) to determine future directions of research and treatment. METHODS: Data from the controlled clinical trials are presented and reviewed for potential opportunities for further research into the treatment of cataracts and AMD. RESULTS: Two trials using daily multivitamins/minerals demonstrated a reduction in the progression of nuclear cataract, but increased the risk of posterior subcapsular cataract. For AMD, the Age-Related Eye Disease Study (AREDS) formulation (vitamins C, E, beta-carotene, zinc, and copper) reduced the risk of progression to advanced AMD by 25% at 5 years. Because beta-carotene is associated with increased lung cancer in former smokers, lutein/zeaxanthin could replace beta-carotene and provide an incremental increase in the beneficial effects beyond the effects of the AREDS formulation. In addition, a randomized clinical trial of B vitamins demonstrated a beneficial effect for AMD with the vitamin B complex. CONCLUSIONS: Future evaluation may include additional assessments of nutrients for the treatment of progression of cataract and AMD. A modest reduction would have significant impact as the numbers of persons affected with these two leading causes of blindness are projected to double in the next decade. An important step would be to develop surrogate outcomes to increase efficiency in clinical trials. More detailed phenotyping, especially of AMD, is required as it appears to be not one disease, but a group of diseases. Genotype-phenotype analyses may help to target pathways that are important in AMD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Causes and Prevalence of Visual Impairment Among Adults in the UnitedStates
(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.477 · Cited by 2,616
Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration
Seddon, J. M. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03520180037032 · Cited by 993
Dietary fat and risk for advanced age-related macular degeneration
Seddon, J. M. (2001) · Archives of Ophthalmology · doi:10.1001/archopht.119.8.1191 · Cited by 408
Seddon, J. M. (2003) · Archives of Ophthalmology · doi:10.1001/archopht.121.12.1728 · Cited by 384
Dietary Antioxidants and the Long-term Incidence of Age-Related Macular Degeneration
Tan, J. S. L., Wang, J. J., Flood, V., Rochtchina, E., Smith, W., & Mitchell, P. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2007.03.083 · Cited by 381
Oral Zinc in Macular Degeneration
Newsome, D. A., Swartz, M., Leone, N. C., Elston, R. C., & Miller, E. (1988) · Archives of Ophthalmology · doi:10.1001/archopht.1988.01060130202026 · Cited by 349 · cited 1×
“This was a single center study of a randomized controlled clinical trial of zinc versus placebo in 151 individuals with early AMD.(41) A daily dose of zinc sulfate (100 mg) versus placebo was tested with 1:1 randomization.”
MethodMarse-Perlman, J. A., Fisher, A. I., Klein, R., Palta, M., Block, G., Millen, A. E., & Wright, J. D. (2001) · American Journal of Epidemiology · doi:10.1093/aje/153.5.424 · Cited by 286
(2007) · Archives of Ophthalmology · doi:10.1001/archopht.125.5.671 · Cited by 283
Cho, E. (2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.6.883 · Cited by 266
VandenLangenberg, G. M., Mares-Perlman, J. A., Klein, R., Klein, B. E. K., Brady, W. E., & Palta, M. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009625 · Cited by 234
SanGiovanni, J. P., Agrón, E., Meleth, A. D., Reed, G. F., Sperduto, R. D., Clemons, T. E., & Chew, E. Y. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.27594 · Cited by 186
Self-citationNeovascular age-related macular degeneration and its relationship to antioxidant intake
Snellen, E. L. M., Verbeek, A. L. M., Van Den Hoogen, G. W. P., Cruysberg, J. R. M., & Hoyng, C. B. (2002) · Acta Ophthalmologica Scandinavica · doi:10.1034/j.1600-0420.2002.800404.x · Cited by 137
Flood, V., Smith, W., Wang, J. J., Manzi, F., Webb, K., & Mitchell, P. (2002) · Ophthalmology · doi:10.1016/s0161-6420(02)01263-0 · Cited by 109
Cited by
NAD metabolism: Implications in aging and longevity
Yaku, K., Okabe, K., & Nakagawa, T. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.05.006 · Cited by 269
Mechanisms of Transport and Delivery of Vitamin A and Carotenoids to the Retinal Pigment Epithelium
Harrison, E. H. (2019) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201801046 · Cited by 97
Chao, S.-C., Nien, C.-W., Iacob, C., Hu, D.-N., Huang, S.-C., & Lin, H.-Y. (2016) · Journal of Ophthalmology · doi:10.1155/2016/8341439 · Cited by 19
Metadata
- Authors
- Chew, E. Y.
- Venue
- Investigative Opthalmology & Visual Science
- Published
- 2013-12-13
- Volume
- 54
- Issue
- 14
- Pages
- ORSF42
- ISSN
- 0146-0404 (ISSN-L)
- 1552-5783
- OpenAlex
- W2076345249
- Cited by
- 50
- References
- 15
- FWCI
- 4.82
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.